Fundamental dimension Equity attribute | NEXNLeader $8.88▼-1.88% Cap $505.7MP/E 38.1x QuantScore62/100 | CRTOPeer $14.88▲+0.07% Cap $729.1MP/E 7.4x QuantScore58/100 | DRCTPeer $0.910.00% Cap $692.1KP/E -0.0x QuantScore35/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
77/100 |
46/100 |
23/100 |
Valuation Multiples, PEG & DCF upside | 86/100 | 100/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 40/100 | 64/100 | 27/100 |
Growth Revenue / earnings growth & margins | 30/100 | 29/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | 77/100 | 50/100 | 92/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 38.1x | 7.4x | -0.0x |
Forward P/E (next FY) | 8.3x | 4.3x | -0.0x |
EV / EBITDA (TTM) | 4.6x | 2.3x | -0.8x |
Price / Sales | 1.3x | 0.4x | 0.0x |
Price / Free Cash Flow | 5.7x | 4.1x | -0.1x |
PEG ratio | -0.55 | -0.38 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 7 / 9 | 4 / 9 |
Altman Z-Score | 2.02 (Grey) | 2.24 (Grey) | -7.21 (Distress) |
Total debt / equity | 0.08 | 0.13 | -2.15 |
Quick ratio | 1.3x | 1.3x | 0.1x |
Interest coverage | 0.1x | 54.6x | -8.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -0.2% | +0.6% | -44.3% |
Net income growth YoY | -29.3% | +29.6% | -203.8% |
Gross margin (TTM) | 77.9% | 53.6% | 19.0% |
Operating margin (FY) | 8.9% | 10.4% | -42.5% |
FCF margin (FY) | 26.9% | 10.7% | -25.9% |
5. Trailing price performancePrice change over period |
1M return | 0.0% | -10.1% | -42.4% |
3M return | -9.6% | -27.2% | -64.3% |
6M return | +20.5% | -22.0% | -62.6% |
Year to date | +35.8% | -27.8% | -93.6% |
1Y return | +3.5% | -27.5% | -98.8% |
3Y return | +166.7% | -48.2% | -99.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $17.79 +100.3% upside | $287.63 +1833.0% upside | $-83.75 -9303.6% premium |
Wall Street consensus target | $11.64 +31.1% · range $10.00–$13.00 | $22.08 +48.4% · range $18.00–$25.00 | $440.00 +48251.6% · range $440.00–$440.00 |
Consensus stance | 92% Buy8% Hold0% Sell | 60% Buy37% Hold3% Sell | 80% Buy20% Hold0% Sell |